secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncternal Therapeutics, Inc. (—)
CIK:        0001260990
Form:       8-K
Filed at:   2023-04-06T23:59:59+00:00
Accession:  0000950170-23-012103
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncternal receives Nasdaq deficiency notice for bid price below $1.00
---------------------------------------------------------------------

- Received Nasdaq deficiency letter on April 4, 2023 due to closing bid price below $1.00 for 30 consecutive business days.
- Has until October 2, 2023 to regain compliance by closing at $1.00 or more for at least 10 consecutive trading days.
- May consider a reverse stock split if approved by stockholders to cure the bid-price deficiency.
- Stock continues trading on Nasdaq Capital Market under ONCT; no immediate delisting impact.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1260990/000095017023012103/0000950170-23-012103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1260990/000095017023012103/onct-20230404.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer